Berkeley Lights, Inc.
Mutant IDH1 Specific T Cell Receptor

Last updated:

Abstract:

This disclosure relates to the production and use of an isolated, purified and/or recombinant T cell receptor (TCR) that specifically binds to a mutant IDH1 protein, or a fragment thereof, wherein the mutant IDH1 protein or fragment thereof comprises an R132H mutation.

Status:
Application
Type:

Utility

Filling date:

7 Aug 2020

Issue date:

25 Mar 2021